← Coming soon·

OPTOMED Optomed Oyj

OMXH · Helsinki — full main listsingle-model previewUpdated 2026-07-11

Single AI model preview (DeepSeek): Optomed Oyj estimate 1.93 € vs market price 1.73 € (+11.6%). Analyst coverage: 3. Experimental research — not investment advice.

Spot
1.73 €
Preview est.
1.93 €
Gap
+11.6%
Analysts
3
Market cap
37 M €
52-week range
1.33 €4.75 €
Sector
healthcare

About the company

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, Optomed Polaris, and Optomed Lumo brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands. The company provides Avenue AI, an AI streamlines eye specialists' work and minimises screening costs; Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Flow, an eyecare management software; and Avenue Telemedicine, a remote analysis solution. In addition, it offers Cancer Screen, a screening process management software; Optomed Radiology Information System, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare provid

Source: Yahoo Finance

Model assumptions (DeepSeek)

Revenue CAGR (5y)
4.0 %
EBIT margin target
6.0 %
WACC
9.0 %
Terminal growth
2.0 %
Model confidence
45 %
The estimate runs these assumptions through the same deterministic valuation engine as the live universe. Valuation Methodology

Weekly snapshots

22.7.3.7.4.7.11.7.
SpotPreview est.
DateSpotPreview est.Gap
2026-07-111.73 €1.93 €+11.6%
2026-07-041.78 €2.12 €+19.1%
2026-07-031.65 €2.21 €+33.6%
2026-07-021.67 €2.35 €+40.9%
Experimental research — not investment advice. Preview estimates come from a single AI model and differ from the live 5-model consensus.